Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet, M; Laprise, J-F; Martin, D; JIT, M; Bénard, É; Gingras, G; Boily, M-C; Alary, M; Baussano, I; Hutubessy, R; Brisson, M;
2021
The Lancet. Infectious diseases, (2021).21 11 10.1016/S1473-3099(20)30860-4.
Replication Data for: Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors.
Uyoga, S; ADETIFA, IM O; OTIENDE, M; Gitonga, JN; Mugo, D; Nyagwange, J; Karanja, HK; Tuju, J; Makale, J; Aman, R; Mwangangi, M; Amoth, P; Kasera, K; Ng'ang'a, W; Chege, E; Yegon, C; Kithi, K; Odhiambo, E; Rotich, T; Orgut, I; Kihara, S; BOTTOMLEY, C; Kagucia, EW; GALLAGHER, KE; Etyang, A; ... SCOTT, JA G.
2021
, Harvard Dataverse (2021).
Simulation results for "COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness".
PEARSON, CA B; BOZZANI, F; PROCTER, SR; DAVIES, NG; Huda, M; JENSEN, HT; KEOGH-BROWN, M; Khalid, M; SWEENEY, S; TORRES-RUEDA, S; EGGO, RM; VASSALL, A; JIT, M;
2021
, Zenodo (2021).
The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
GLYNN, JR; Dube, A; FIELDING, K; CRAMPIN, AC; Karonga Prevention Trial Group,; Kanjala, C; FINE, PE M;
2021
The Lancet. Infectious diseases, (2021).21 11 10.1016/S1473-3099(20)30994-4.
"From my phone, I could rule the world": Critical engagement with maternal vaccine information, vaccine confidence builders and post-Zika outbreak rumours in Brazil.
Simas, C; PATERSON, P; LEES, S; J Larson, H;
2021
Vaccine, (2021).39 33 10.1016/j.vaccine.2021.06.039.
A Dose Reduction Immunobridging and Safety Study of two HPV vaccines in Tanzanian girls: serology & immunobridging.
WATSON-JONES, D;
2021
(2021).
Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review.
SAADI, N; Chi, Y-L; Ghosh, S; EGGO, RM; MCCARTHY, C; QUAIFE, M; Dawa, J; JIT, M; VASSALL, A;
2021
medRxiv (2021). 10.1101/2021.06.21.21259104.
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
Patel, MK; Bergeri, I; Bresee, JS; Cowling, BJ; Crowcroft, NS; Fahmy, K; Hirve, S; Kang, G; Katz, MA; Lanata, CF; L'Azou Jackson, M; Joshi, S; Lipsitch, M; Mwenda, JM; Nogareda, F; Orenstein, WA; Ortiz, JR; Pebody, R; Schrag, SJ; SMITH, PG; Srikantiah, P; Subissi, L; Valenciano, M; Vaughn, DW; Verani, JR; ... Feikin, DR.
2021
Vaccine, (2021).39 30 10.1016/j.vaccine.2021.05.099.
Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis.
SANDMANN, F; JIT, M; Andrews, N; Buckley, HL; Campbell, H; Ribeiro, S; Sile, B; Stowe, J; Tessier, E; Ramsay, M; Amirthalingam, G; Choi, YH;
2021
Vaccine, (2021).39 32 10.1016/j.vaccine.2021.06.042.
Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
Gaythorpe, KA; ABBAS, K; Huber, J; Karachaliou, A; Thakkar, N; Woodruff, K; Li, X; Echeverria-Londono, S; VIMC Working Group on COVID-19 Impact on Vaccine P,; Ferrari, M; Jackson, ML; McCarthy, K; Perkins, TA; Trotter, C; JIT, M;
2021
eLife, (2021).10, 10.7554/eLife.67023.